Victory Capital Management Inc. trimmed its position in LiveRamp Holdings, Inc. (NYSE:RAMP - Free Report) by 53.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,011 shares of the company's stock after selling 19,191 shares during the period. Victory Capital Management Inc.'s holdings in LiveRamp were worth $422,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also bought and sold shares of RAMP. DT Investment Partners LLC acquired a new position in LiveRamp in the second quarter valued at about $27,000. Quarry LP grew its position in shares of LiveRamp by 4,575.0% in the 2nd quarter. Quarry LP now owns 935 shares of the company's stock valued at $29,000 after purchasing an additional 915 shares during the period. Blue Trust Inc. increased its stake in LiveRamp by 187.1% during the 2nd quarter. Blue Trust Inc. now owns 1,065 shares of the company's stock worth $33,000 after purchasing an additional 694 shares in the last quarter. DekaBank Deutsche Girozentrale acquired a new stake in LiveRamp during the 1st quarter worth approximately $87,000. Finally, Quest Partners LLC lifted its stake in LiveRamp by 68.8% in the second quarter. Quest Partners LLC now owns 2,998 shares of the company's stock valued at $93,000 after buying an additional 1,222 shares in the last quarter. Institutional investors own 93.83% of the company's stock.
LiveRamp Stock Performance
RAMP traded down $0.08 during trading on Friday, reaching $30.36. 196,541 shares of the stock were exchanged, compared to its average volume of 643,676. The stock has a market cap of $1.98 billion, a P/E ratio of 609.52 and a beta of 0.96. The stock's 50 day moving average price is $26.28 and its two-hundred day moving average price is $27.96. LiveRamp Holdings, Inc. has a twelve month low of $21.45 and a twelve month high of $42.66.
LiveRamp (NYSE:RAMP - Get Free Report) last issued its earnings results on Wednesday, November 6th. The company reported $0.51 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.37 by $0.14. LiveRamp had a net margin of 0.40% and a return on equity of 1.25%. The company had revenue of $185.00 million for the quarter, compared to analysts' expectations of $176.16 million. During the same period in the prior year, the firm earned $0.21 EPS. LiveRamp's quarterly revenue was up 15.6% compared to the same quarter last year. Equities research analysts predict that LiveRamp Holdings, Inc. will post 0.36 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on the company. Evercore ISI decreased their price objective on LiveRamp from $50.00 to $40.00 and set an "outperform" rating for the company in a report on Thursday, August 8th. Macquarie reaffirmed an "outperform" rating and set a $43.00 price target on shares of LiveRamp in a research note on Thursday, November 7th. Wells Fargo & Company assumed coverage on shares of LiveRamp in a research report on Monday, October 28th. They issued an "equal weight" rating and a $25.00 price objective on the stock. Craig Hallum decreased their target price on shares of LiveRamp from $55.00 to $43.00 and set a "buy" rating for the company in a research report on Thursday, August 8th. Finally, Benchmark cut their price target on shares of LiveRamp from $48.00 to $42.00 and set a "buy" rating on the stock in a research report on Thursday, November 7th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $41.14.
Check Out Our Latest Stock Report on LiveRamp
Insider Buying and Selling at LiveRamp
In other news, Director Debora B. Tomlin sold 9,765 shares of the business's stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $25.07, for a total transaction of $244,808.55. Following the completion of the sale, the director now owns 24,509 shares in the company, valued at $614,440.63. The trade was a 28.49 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Kimberly Bloomston sold 4,000 shares of the stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $25.17, for a total value of $100,680.00. Following the transaction, the insider now owns 117,247 shares in the company, valued at approximately $2,951,106.99. This trade represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders own 3.39% of the company's stock.
LiveRamp Profile
(
Free Report)
LiveRamp Holdings, Inc, a technology company, operates a data collaboration platform in the United States, Europe, the Asia-Pacific, and internationally. The company operates LiveRamp Data Collaboration platform enables an organization to unify customer and prospect data to build a single view of the customer in a way that protects consumer privacy.
Further Reading
Before you consider LiveRamp, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LiveRamp wasn't on the list.
While LiveRamp currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.